Shany Koren and Mohamed Bentires-Alj Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors FEBS Journal 280
The phosphoinositide 3-kinase (PI3K) signaling pathway is frequently deregulated in human cancer. PIK3CA, the gene encoding the catalytic subunit p110α of PI3K, is mutated in ~30% of breast cancers. Here, we describe current mouse models harboring the hotspot mutation PIK3CA H1047R in the mammary gland and discuss differences in tumor latency and pathogenesis.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf